TCL Archive ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication February 17, 2012
TCL Archive Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial October 26, 2012
TCL Archive Nominations Sought For Paul Marks Prizes, Recognizing Discoverise By The Under-45 Set. April 13, 2001
TCL Archive Pressure Builds On President To Sign Authorization Bill; No Movement Yet On Appropriations Measure November 8, 1985
TCL Archive DCPC Board Commits More Than $100 Million To 15-Year Trial Of Low Fat Diet In Women October 26, 1990
